Forget California’s huge budget deficits, high unemployment levels and nasty political campaigns. One of the most polarizing issues in the Golden State today is about a proposal to ban Happy Meals toys in San Francisco.
…
Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it incr…
There’s a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than …
A new study from Columbia University finds that the reasons America is lagging other countries aren’t the commonly cited obesity, smoking, traffic fatalities and homicide. Rather, the problem has been poor health care, or rathe…
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…